{"nct_id":"NCT04249362","title":"Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy","status":"COMPLETED","status_verified_date":"2024-12","start_date":"2020-11-26","start_date_type":"ACTUAL","primary_completion_date":"2023-03-30","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-25","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}